Associated Papers
The role of 5-hydroxytryptamine receptor 2A (HTR2A) gene polymorphisms in treatment-resistant obsessive-compulsive disorder: a comparative study with other treatment-resistant mental disorders.
Del Casale A et al.
Bmc Psychiatry, 2025
The association of HTR2A polymorphisms with obsessive-compulsive disorder and its subtypes: A meta-analysis.
Mattina GF et al.
Journal of Affective Disorders, 2020
Association of serotonin receptor 2a haplotypes with obsessive-compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study.
Sina M et al.
Neuropsychiatric Disease and Treatment, 2018
A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics.
Baou M et al.
Schizophrenia Research, 2016
Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies.
Taylor S
Molecular Psychiatry, 2013
Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse.
Herman AI et al.
Substance Abuse and Rehabilitation, 2012
Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.
Corregiari FM et al.
Clinics (sao Paulo, Brazil), 2012
Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment.
Miguita K et al.
Arquivos De Neuro-psiquiatria, 2011
Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia.
Olajossy-Hilkesberger L et al.
Neuropsychobiology, 2011
Role of 2 common variants of 5HT2A gene in medication overuse headache.
Terrazzino S et al.
Headache, 2010
Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions.
Thomas KL et al.
Pharmacotherapy, 2009
Genetic loading on human loving styles.
Emanuele E et al.
Neuro Endocrinology Letters, 2007
Genetics of obsessive-compulsive disorder: a research update.
Grados M et al.
Expert Review of Neurotherapeutics, 2007
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.
Kiferle L et al.
Neuroscience Letters, 2007
Association analysis between the C516T polymorphism in the 5-HT2A receptor gene and schizophrenia.
Bertola V et al.
Arquivos De Neuro-psiquiatria, 2007
HTR2A: association and expression studies in neuropsychiatric genetics.
Norton N et al.
Annals of Medicine, 2005
Lack of association between 5HT2A receptor gene haplotype, bipolar disorder and its clinical subtypes in a West European sample.
Etain B et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2004
Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.
Meira-Lima I et al.
Genes, Brain, and Behavior, 2004
Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder.
Ranade SS et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2003
Family-based association study of the serotonin-2A receptor gene (5-HT2A) and bipolar disorder.
Ni X et al.
Neuromolecular Medicine, 2002
Genetic variation of the 5-HT2A receptor gene and bipolar affective disorder.
Gutiérrez B et al.
Human Genetics, 1997
Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese.
Chen CH et al.
Psychiatric Genetics, 1997
Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia.
Erdmann J et al.
Human Genetics, 1996
Association between clozapine response and allelic variation in 5-HT2A receptor gene.
Arranz M et al.
Lancet (london, England), 1995
Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.
Davies MA et al.
The Pharmacogenomics Journal, 0
Allele and genotype frequencies of serotonin and dopamine transporter and receptor polymorphisms in a Norwegian population.
Güzey C et al.
Genetic Testing and Molecular Biomarkers, 0
Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms.
Blum K et al.
Journal of Psychoactive Drugs, 0